Valley Fever Solutions

Bringing New Hope to an Orphan Disease

Valley Fever Solutions
Ask your doctor to test you for Valley Fever

More Details


Valley Fever Solutions, Inc. (VFS, an Arizona corporation), is developing Nikkomycin Z (NikZ), first of a new class of antifungals, as a dramatically superior potential cure for Valley Fever, a painful and debilitating orphan disease causing over 2,000 serious cases and 150 deaths a year.

We recently were awarded funding to scale up the API drug substance manufacturing process. We expect a good quantity of bulk drug product in late February. We expect this will confirm a process for multi-kg scale runs as soon as support is available. We have tentative support for this scale up. Private funding would let us proceed as soon as funding is available.

executive summary
Valley Fever Solutions - Executive Summary
Powerpoint - Investor Summary - Biotech Showcase 2017
What Can be Done - Disease Background and Treatment Direction
investor summary
valley fever ppt